CHEMOTHERAPY OF TRYPANOSOMIASIS - THE POTENTIATION OF MELARSOPROL BY CONCURRENT DIFLUOROMETHYLORNITHINE (DFMO) TREATMENT

被引:16
作者
JENNINGS, FW
机构
关键词
D O I
10.1016/0035-9203(88)90512-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:572 / 573
页数:2
相关论文
共 9 条
[1]  
Apted F. I. C., 1970, P684
[2]   POLYAMINE METABOLISM - A POTENTIAL THERAPEUTIC TARGET IN TRYPANOSOMES [J].
BACCHI, CJ ;
NATHAN, HC ;
HUTNER, SH .
SCIENCE, 1980, 210 (4467) :332-334
[3]   NECESSITY OF ANTIBODY-RESPONSE IN THE TREATMENT OF AFRICAN TRYPANOSOMIASIS WITH ALPHA-DIFLUOROMETHYLORNITHINE [J].
BITONTI, AJ ;
MCCANN, PP ;
SJOERDSMA, A .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (02) :331-334
[4]  
DEGEE ALW, 1983, J PARASITOL, V69, P818, DOI 10.2307/3281038
[5]  
DERAADT P, 1984, MED INT, P146
[6]   MSB AND MSBB IN THE TREATMENT OF SLEEPING SICKNESS DUE TO INFECTION WITH TRYPANOSOMA-GAMBIENSE [J].
FRIEDHEIM, EAH .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1953, 47 (04) :350-360
[7]   TRYPANOTHIONE METABOLISM - A CHEMOTHERAPEUTIC TARGET IN TRYPANOSOMATIDS [J].
HENDERSON, GB ;
FAIRLAMB, AH .
PARASITOLOGY TODAY, 1987, 3 (10) :312-315
[8]  
KUZOE FAS, 1987, TROPICAL DISEASE RES, P71
[9]   TREATMENT OF GAMBIENSE SLEEPING SICKNESS IN THE SUDAN WITH ORAL DFMO "(DL-ALPHA-DIFLUOROMETHYLORNITHINE), AN INHIBITOR OF ORNITHINE DECARBOXYLASE 1ST-FIELD TRIAL [J].
VANNIEUWENHOVE, S ;
SCHECHTER, PJ ;
DECLERCQ, J ;
BONE, G ;
BURKE, J ;
SJOERDSMA, A .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1985, 79 (05) :692-698